A second generation of C3 humanized rats for preclinical evaluation of human C3 inhibitors
{{output}}
Complement component 3 (C3) is an attractive therapeutic target for several inflammatory diseases; however, the strict primate specificity of emerging C3 inhibitors mandates the use of nonhuman primates (NHPs) for preclinical evaluation, creating significant e... ...
